4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001415889-25-002004
SVP, GC & CORPORATE SECRETARY sold 2,437 shares at $19.46 ($47,424)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
REED ELIZABETH E · SVP, GC & CORPORATE SECRETARY
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-22 | Sale : show line 1 in the form 10b5-1 | −2,437 | $19.46 | $47,424 | 76,933 | D |
| Open-market sales · 2,437 sh · avg $19.46 · $47,424 | ||||||
Loading xslF345X05/form4-01242025_010150.xml…